The Clorox Company (NYSE:CLX) Shares Acquired by Archer Investment Corp

Archer Investment Corp boosted its stake in The Clorox Company (NYSE:CLX) by 4,023.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,639 shares of the company’s stock after purchasing an additional 2,575 shares during the period. Archer Investment Corp’s holdings in Clorox were worth $430,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the stock. Van ECK Associates Corp boosted its position in Clorox by 1,715.5% in the 2nd quarter. Van ECK Associates Corp now owns 1,461,207 shares of the company’s stock valued at $199,411,000 after buying an additional 1,380,724 shares during the last quarter. Nuance Investments LLC lifted its position in shares of Clorox by 150.6% during the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock worth $218,035,000 after purchasing an additional 960,094 shares during the last quarter. Wulff Hansen & CO. lifted its position in shares of Clorox by 13,547.0% during the second quarter. Wulff Hansen & CO. now owns 440,116 shares of the company’s stock worth $60,063,000 after purchasing an additional 436,891 shares during the last quarter. International Assets Investment Management LLC raised its stake in Clorox by 424.9% during the third quarter. International Assets Investment Management LLC now owns 538,576 shares of the company’s stock worth $877,390,000 after acquiring an additional 435,971 shares during the period. Finally, Boston Trust Walden Corp raised its stake in Clorox by 5,442.5% during the third quarter. Boston Trust Walden Corp now owns 273,908 shares of the company’s stock worth $44,622,000 after acquiring an additional 268,966 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. This represents a 11.40 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.57% of the stock is currently owned by insiders.

Clorox Stock Up 0.3 %

Shares of Clorox stock traded up $0.48 on Friday, hitting $166.23. 96,056 shares of the company traded hands, compared to its average volume of 1,236,676. The company has a 50-day moving average price of $162.39 and a 200 day moving average price of $147.34. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $169.09. The company has a market cap of $20.58 billion, a PE ratio of 58.07, a PEG ratio of 3.06 and a beta of 0.41.

Clorox (NYSE:CLX) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the previous year, the business earned $0.49 EPS. Clorox’s quarterly revenue was up 27.0% compared to the same quarter last year. Sell-side analysts predict that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd were paid a $1.22 dividend. The ex-dividend date was Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 2.94%. Clorox’s payout ratio is currently 170.04%.

Analysts Set New Price Targets

CLX has been the topic of several research reports. DA Davidson increased their price objective on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a research note on Friday, September 6th. JPMorgan Chase & Co. raised their price target on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research note on Friday, October 11th. Citigroup raised their price objective on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Finally, TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and raised their target price for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Five investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $155.00.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.